Also listed on Medtor LLC, an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Jan 14, 2031 · High confidence
20-year base term ends Jun 15, 2027
Held by Biointellisense, Inc.
Filed Jun 15, 2007 as application 11/818,898 · Granted Sep 18, 2012
Base term plus 1309 days of patent term adjustment (USPTO delay)
Today
2007
2031
Clock starts
Jun 15, 2007
Jun 15, 2007
Term ends
Jan 14, 2031
Jan 14, 2031
Granted
Sep 18, 2012
Sep 18, 2012
base term
patent term adjustment
fee events
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
1,309
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
This patent's term runs 1309 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jun 15, 2007, when this application, 11/818,898, was filed | Jun 15, 2027 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +1309 days, USPTO patent term adjustment record | Jan 14, 2031 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jan 14, 2031 | High confidence |
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Sep 21, 2007 Reel 19884, frame 212 | Dietiker, Thomas | Medtor, LLC | Assignment of Assignor's Interest |
| Dec 3, 2020 Reel 54538, frame 882 | Medtor, Inc.; Dietiker, Thomas | Osi Optoelectronics, Inc. | Security Interest |
| Aug 6, 2021 Reel 57113, frame 46 | Medtor LLC | Medtor, Inc. | Entity Conversion and Name Change |
| Nov 16, 2021 Reel 58159, frame 68 | Osi Optoelectronics, Inc. | Medtor, Inc.; Dietiker, Thomas | Release of Security Interest |
| Nov 16, 2021 reel/frame not recorded | Osi Optoelectronics, Inc. | Medtor, Inc. | Release of Security Interest |
| Nov 16, 2021 reel/frame not recorded | Osi Optoelectronics, Inc. | Dietiker, Thomas | Release of Security Interest |
| May 3, 2023 Reel 63523, frame 935 | Medtor, Inc.; Biointellisense, Inc. | Biointellisense, Inc. | Merger and Change of Name |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Jan 2031
Term ends Jan 14, 2031. No further fees fall due before then
Note
The 1309 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
48
later US patents cite this one
That is top 25% of utility patents granted in 2012 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.